PROPOFOL KABI 20 mg/ml, injectable emulsion in a pre-filled syringe syringe, 50 ml
Active ingredients: Propofol
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Injectable emulsionsyringe, 50 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PROPOFOL KABI 20 mg/mL, émulsion injectable en seringue pré-remplie
- Pharmaceutical form
- émulsion injectable
- Route of administration
- intraveineuse
- Presentation description
- 1 seringue(s) préremplie(s) en verre de 50 ml
- Marketing authorisation holder
- FRESENIUS KABI FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 Mar 2024
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Emergency use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68749814CIP75506736CIP133400955067368Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PROPOFOLémulsion | 20 mg · 1 mL d'émulsion | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.